English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine MedTech
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Jun 25, 2024 20:00 HKT
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
Jun 18, 2024 18:45 HKT
Vinmec's Innovations Spotlighted at Global CSR & ESG Summit 2024
May 09, 2024 05:04 HKT
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Apr 23, 2024 22:00 HKT
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Apr 16, 2024 17:04 HKT
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Apr 01, 2024 20:30 HKT
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
Mar 28, 2024 10:23 HKT
How AI, Genetics and Biotechnology Revolutions will Transform our Future: Jamie Metzl at the Global AI Show
Mar 25, 2024 07:45 HKT
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
Mar 21, 2024 09:00 HKT
TechInvention Lifecare announces the groundbreaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures
Feb 28, 2024 09:00 HKT
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
Feb 04, 2024 09:00 HKT
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
Jan 02, 2024 14:00 HKT
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
Dec 13, 2023 17:00 HKT
Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure
Dec 05, 2023 22:00 HKT
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 04, 2023 21:49 HKT
MedTech Innovations and Digital Breakthroughs: Announcing the 2023 Pharma IT Summit for a Future-Ready Pharmaceutical Landscape
Dec 01, 2023 17:55 HKT
OrbusNeich Acquires 84% Stake in Indonesian Distributor PT Revass for Approximately US$15 Million
Nov 27, 2023 09:00 HKT
Indonesia's ITS Launches 7 MedTech Devices Based on Various Integrated Technologies
Nov 09, 2023 21:00 HKT
Clinical Squared and PlatoHealth Join Forces to Revolutionize Healthcare with Advanced Data Orchestration Powered by AI
Sep 21, 2023 14:29 HKT
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
Aug 24, 2023 20:00 HKT
Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: